Company Eidos Therapeutics, Inc.
Equities
EIDX
US28249H1041
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Neil Kumar
CEO | Chief Executive Officer | 45 | 16-02-29 |
Jonathan Fox
PSD | President | 66 | 16-09-30 |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 16-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 16-05-31 |
Jonathan A. Barr
BRD | Director/Board Member | - | 21-01-25 |
Jonathan Fox
PSD | President | 66 | 16-09-30 |
Neil Kumar
CEO | Chief Executive Officer | 45 | 16-02-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,872,893 | 12,835,887 ( 33.02 %) | 0 | 33.02 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |